Heliyon
Corrigendum to "Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model" [Heliyon Volume 9, Issue 5, May 2023, Article e16217].
Hatem Abuohashish, Abdulaziz Alamri, Suliman Shahin, Dalal Almazrou, Taleb Alkhamis, Omar Omar
Published: 202510.1016/j.heliyon.2025.e43311
Abstract
Open Access[This corrects the article DOI: 10.1016/j.heliyon.2023.e16217.].